etoposide,gemtuzumab ozogamicin,midostaurin
pfizer,ucb pharmaceuticals,novartis
['gemtuzumab', 'bet', 'leusm', 'etoposide', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'midostaurin', 'mds']
congress | #ash22 nigel h russell presented results from the ncri aml19 trial of 1475 pts with newly diagnosed #aml / mds-eb2, treated with gemtuzumab ozogamicin and either flag-ida or daunorubicin-arac. flag-ida + go provided significant imporvement in efs vs da + go.
#leusm 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm